Evidence map›Paper›PMID 42395605›Full record

ArticleFrontiers in pediatrics2026

Impact of high disease activity on damage accrual and disease outcomes in childhood-onset systemic lupus erythematosus.

Ninlapat Jidmahawong, Butsabong Lerkvaleekul, Kwanchai Pirojsakul, Soamarat Vilaiyuk

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ninlapat Jidmahawong *Division of Rheumatology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Butsabong Lerkvaleekul *Division of Rheumatology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Kwanchai PirojsakulDivision of Nephrology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Soamarat VilaiyukDivision of Rheumatology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The impact of the duration and cumulative high disease activity on damage accrual in childhood-onset SLE (cSLE) is less well established. This study aimed to assess the cumulative burden of high disease activity and its association with damage accrual and clinical outcomes in patients with cSLE. Methods: This retrospective cohort study included cSLE patients with at least one year of follow-up. High disease activity status (HDAS) was defined as a SLEDAI-2 K score ≥10. Patients were classified into two groups: HDAS (ever experienced HDAS) and non-HDAS. Time-adjusted cumulative HDAS (cHDAS) was defined as the proportion of time spent in HDAS during the observation period. Clinical features, laboratory parameters, treatment, organ damage assessed by the SLICC/ACR Damage Index, and remission status were recorded at baseline and each follow-up visit. Logistic regression, Cox proportional hazards models, and Kaplan-Meier analyses were performed. Results: Among 196 cSLE (mean age at diagnosis 11.3 ± 2.9 years; 82.1% female), 126 (64.3%) experienced high disease activity status (HDAS). Patients with HDAS had a significantly higher rate of damage accrual than those without (SDI ≥ 1: 33.3% vs. 11.4%, Conclusions: Higher time-adjusted cHDAS was associated with an increased risk of damage accrual, indicating that greater cumulative exposure to high disease activity is associated with damage. Neuropsychiatric involvement and time-adjusted cHDAS ≥5% were significantly associated with damage accrual.

Indexed as

childrenconnective tissue diseasecorticosteroidsdamagehigh disease activitylupusoutcomes

Identifiers

PMID42395605
PMCPMC13323140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.